247 related articles for article (PubMed ID: 12047649)
1. Efficacy of imiquimod 5% cream in the treatment of recalcitrant warts in children.
Grussendorf-Conen EI; Jacobs S
Pediatr Dermatol; 2002; 19(3):263-6. PubMed ID: 12047649
[TBL] [Abstract][Full Text] [Related]
2. Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus.
Edwards L; Ferenczy A; Eron L; Baker D; Owens ML; Fox TL; Hougham AJ; Schmitt KA
Arch Dermatol; 1998 Jan; 134(1):25-30. PubMed ID: 9449906
[TBL] [Abstract][Full Text] [Related]
3. Topical 5% imiquimod long-term treatment of cutaneous warts resistant to standard therapy modalities.
Grussendorf-Conen EI; Jacobs S; Rübben A; Dethlefsen U
Dermatology; 2002; 205(2):139-45. PubMed ID: 12218229
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy and safety of 5% imiquimod cream in external genital warts: a 6 month follow-up evaluation].
Vexiau D; Decuypère L; Moyse D; Aractingi S
Ann Dermatol Venereol; 2005 Nov; 132(11 Pt 1):845-51. PubMed ID: 16327713
[TBL] [Abstract][Full Text] [Related]
5. Topical imiquimod: a review of its use in genital warts.
Perry CM; Lamb HM
Drugs; 1999 Aug; 58(2):375-90. PubMed ID: 10473026
[TBL] [Abstract][Full Text] [Related]
6. Management of female genital warts with an analog of imiquimod 2% in cream: a randomized, double-blind, placebo-controlled study.
Syed TA; Ahmadpour OA; Ahmad SA; Ahmad SH
J Dermatol; 1998 Jul; 25(7):429-33. PubMed ID: 9714974
[TBL] [Abstract][Full Text] [Related]
7. Treatment of genital warts with an immune-response modifier (imiquimod).
Beutner KR; Spruance SL; Hougham AJ; Fox TL; Owens ML; Douglas JM
J Am Acad Dermatol; 1998 Feb; 38(2 Pt 1):230-9. PubMed ID: 9486679
[TBL] [Abstract][Full Text] [Related]
8. Vagarious successful treatment of recalcitrant warts in combination with CO2 laser and imiquimod 5% cream.
Zeng Y; Zheng YQ; Wang L
J Cosmet Laser Ther; 2014 Dec; 16(6):311-3. PubMed ID: 25148409
[TBL] [Abstract][Full Text] [Related]
9. Fractional Laser-Assisted Topical Imiquimod 5% Cream Treatment for Recalcitrant Common Warts in Children: A Pilot Study.
Park SM; Kim GW; Mun JH; Song M; Kim HS; Kim BS; Kim MB; Ko HC
Dermatol Surg; 2016 Dec; 42(12):1340-1346. PubMed ID: 27598444
[TBL] [Abstract][Full Text] [Related]
10. Plantar warts treated with an immune response modifier: a report of two cases.
Zamiri M; Gupta G
Clin Exp Dermatol; 2003 Nov; 28 Suppl 1():45-7. PubMed ID: 14616815
[TBL] [Abstract][Full Text] [Related]
11. Imiquimod in the treatment of cutaneous warts: an evidence-based review.
Ahn CS; Huang WW
Am J Clin Dermatol; 2014 Oct; 15(5):387-99. PubMed ID: 25186654
[TBL] [Abstract][Full Text] [Related]
12. [Imiquimod in the treatment of recalcitrant warts: a new therapy option?].
Hesterberg U; Böhlen LM; Brand CU
Praxis (Bern 1994); 2003 Mar; 92(12):535-9. PubMed ID: 12693144
[TBL] [Abstract][Full Text] [Related]
13. Topical imiquimod for recalcitrant facial flat warts.
Schwab RA; Elston DM
Cutis; 2000 Mar; 65(3):160-2. PubMed ID: 10738635
[TBL] [Abstract][Full Text] [Related]
14. Imiquimod cream 5% for recalcitrant cutaneous warts in immunosuppressed individuals.
Harwood CA; Perrett CM; Brown VL; Leigh IM; McGregor JM; Proby CM
Br J Dermatol; 2005 Jan; 152(1):122-9. PubMed ID: 15656812
[TBL] [Abstract][Full Text] [Related]
15. Randomized, comparative trial on the sustained efficacy of topical imiquimod 5% cream versus conventional ablative methods in external anogenital warts.
Schöfer H; Van Ophoven A; Henke U; Lenz T; Eul A
Eur J Dermatol; 2006; 16(6):642-8. PubMed ID: 17229604
[TBL] [Abstract][Full Text] [Related]
16. Treatment of facial verrucae with topical imiquimod cream in a patient with human immunodeficiency virus.
Cutler K; Kagen MH; Don PC; McAleer P; Weinberg JM
Acta Derm Venereol; 2000; 80(2):134-5. PubMed ID: 10877136
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of butcher's warts with imiquimod 5% cream.
Poochareon V; Berman B; Villa A
Clin Exp Dermatol; 2003 Nov; 28 Suppl 1():42-4. PubMed ID: 14616814
[TBL] [Abstract][Full Text] [Related]
18. Imiquimod 5% cream for external genital or perianal warts in human immunodeficiency virus-positive patients treated with highly active antiretroviral therapy: an open-label, noncomparative study.
Saiag P; Bauhofer A; Bouscarat F; Aquilina C; Ortonne JP; Dupin N; Mougin C
Br J Dermatol; 2009 Oct; 161(4):904-9. PubMed ID: 19466962
[TBL] [Abstract][Full Text] [Related]
19. Topical treatment of common warts in an HIV-positive patient with imiquimod 5% cream.
Juschka U; Hartmann M
Clin Exp Dermatol; 2003 Nov; 28 Suppl 1():48-50. PubMed ID: 14616816
[TBL] [Abstract][Full Text] [Related]
20. Topical imiquimod 5% cream as an effective treatment for external genital and perianal warts in different patient populations.
Sauder DN; Skinner RB; Fox TL; Owens ML
Sex Transm Dis; 2003 Feb; 30(2):124-8. PubMed ID: 12567169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
